[Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy]
- PMID: 1694944
[Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy]
Abstract
We report two patients with large-cell non-Hodgkin's lymphomas who were treated with intensive chemotherapy (MACOP-B), and in whom large isolated intraparenchymal masses (splenic in one case, renal in the other) were found with computed tomography after clinical remission. It was found at surgery that both masses were constituted by acellular necrotic material, without tumoral infiltration and limited by fibrous tissue. The finding of these residual masses in patients in remission raises problems of approach, as they may be nontumoral and not require new therapy. At present, until new radiological or biochemical markers are available, a judicious clinical attitude should be taken, with radiological control of the evolution of the masses and reserving surgery only for those cases with progression, diagnostic doubts, or patient's decision to know his real status.
Similar articles
-
Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.J Assoc Physicians India. 1994 Oct;42(10):781-4. J Assoc Physicians India. 1994. PMID: 7533151 Clinical Trial.
-
Complete remission by chemotherapy in stage IE-IIE primary gastric lymphoma.Hepatogastroenterology. 2007 Jun;54(76):1285-8. Hepatogastroenterology. 2007. PMID: 17629090
-
[Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].Vnitr Lek. 1989 Dec;35(12):1177-82. Vnitr Lek. 1989. PMID: 2483776 Czech.
-
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.J Clin Oncol. 2003 Jun 1;21(11):2115-22. doi: 10.1200/JCO.2003.07.111. J Clin Oncol. 2003. PMID: 12775737 Review.
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
Cited by
-
Magnetic resonance imaging for the assessment of residual masses after treatment of non-Hodgkin's lymphomas.Postgrad Med J. 1992 Aug;68(802):643-7. doi: 10.1136/pgmj.68.802.643. Postgrad Med J. 1992. PMID: 1448405 Free PMC article.